Roche (OTCMKTS:RHHVF)‘s stock had its “buy” rating reissued by equities researchers at Deutsche Bank Aktiengesellschaft in a research report issued on Wednesday, AnalystRatings.com reports.
A number of other equities research analysts also recently weighed in on RHHVF. Jefferies Financial Group reissued a “buy” rating on shares of Roche in a report on Tuesday, September 7th. JPMorgan Chase & Co. reissued a “hold” rating on shares of Roche in a report on Friday, September 17th. Finally, Sanford C. Bernstein reaffirmed a “buy” rating on shares of Roche in a research note on Tuesday, August 10th. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Buy”.
Shares of OTCMKTS RHHVF opened at $388.50 on Wednesday. Roche has a twelve month low of $308.57 and a twelve month high of $411.44. The firm has a 50-day moving average of $385.35 and a two-hundred day moving average of $378.71.
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process.
See Also: What is Blockchain?
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.